Haoxi Health Technology Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haoxi Health Technology Ltd, a foreign private issuer, covers the month of April 2025. The report was filed on April 14, 2025, and primarily addresses a change in senior management regarding the Chief Financial Officer position.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
- Resignation: Ms. Yu Guo resigned as Chief Financial Officer effective April 10, 2025, citing personal reasons with no disagreement regarding company operations.
- Appointment: Ms. Dongxue Li was appointed as the new CFO, effective April 12, 2025.
- Compensation: Ms. Li's annual compensation is set at $12,000.
- Term: The appointment is for a one-year term, renewable for successive one-year terms.
Outlook, Risks, and Management Commentary
Management confirmed that the departure of the previous CFO was not due to any disagreement with the Company. Ms. Li brings prior experience as a financial reporting manager at a wholly owned subsidiary and previously served as a senior finance manager at an external firm. There are no disclosed family relationships between Ms. Li and company directors, nor any undisclosed arrangements regarding her appointment.
Key Facts for Investor Verification
- Verify the effective dates of the CFO transition (April 10 resignation, April 12 appointment).
- Confirm the biographical background of Ms. Dongxue Li, specifically her tenure at Beijing Haoxi Digital Technology Co., Ltd. since August 2024.
- Note the specific annual compensation of $12,000 for the new CFO role.
- Review the attached Employment Agreement (Exhibit 10.1) for further contractual details.